期刊文献+

对1例腹膜透析伴左下肢截肢术后患者的药物治疗分析与药学监护

Pharmaceutical Care for a Patient with Peritoneal Dialysis and Left Lower Limb Amputation
下载PDF
导出
摘要 本文介绍临床药师参与1例腹膜透析伴左下肢截肢术后患者的诊疗过程,分析腹膜透析伴左下肢截肢术后药物治疗并小结药学监护的经验。临床药师结合患者腹膜透析的特殊病理状态,在碘造影剂、抗栓药物、镇痛药物及低钾血症处理方面,从药物选择、剂量调整、给药途径等角度进行分析,提供药学建议,并进行药学监护,充分发挥了临床药师在疾病治疗过程中的协同作用,促进临床合理用药。 To analyze the drug therapy on a patient with peritoneal dialysis and left lower limb amputation,and summarize the experience of pharmaceutical care.Clinical pharmacist participated in treatment of a peritoneal dialysis with left lower limb amputation,in combination with the special pathological state of peritoneal dialysis,iodine contrast agents,anticoagulant drugs,analgesics and hypokalemia were analyzed from the perspective of drug selection,dose adjustment and route of administration,provided pharmaceutical suggestions and performed pharmaceutical care.Clinical pharmacists take an active part in clinical treatment,give full play to the synergistic effect,and promote the rational use of medicine in clinic.
作者 张在丽 李莉霞 崔敏 张誉艺 王轶 Zhang Zaili;Li Lixia;Cui Min;Zhang Yuyi;Wang Yi(Department of Pharmacy,Renji Hospital,School of Medicinem,Shanghai Jiaotong University,Shanghai200127,China;Department of Pharmacy,Xinhua Hospital,School of Medicinem,Shanghai Jiaotong University;Department of Pharmacy,East Hospital Affiliated to Tongji University;Department of Pharmacy,Huashan North Hospital to Fudan University)
出处 《药物流行病学杂志》 CAS 2019年第9期603-607,共5页 Chinese Journal of Pharmacoepidemiology
基金 上海市临床药学重点专科建设项目(编号:2016-40044-002) 上海市卫生计生系统重要薄弱学科建设项目(编号:2016ZB0304)
关键词 临床药师 腹膜透析 碘造影剂 抗栓治疗 药学监护 Clinical pharmacist Peritoneal dialysis Iodine contrast agent Antithrombotic therapy Pharmaceutical care
  • 相关文献

参考文献7

二级参考文献50

  • 1程通,万启军,何永成.腹膜透析低钾血症的原因、危害及防治[J].中国血液净化,2012,11(7):399-401. 被引量:9
  • 2胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 3国家"十五"攻关"肺栓塞规范化诊治方法的研究"课题组,杨媛华,翟振国,武燕兵,王辰.急性肺血栓栓塞症患者516例临床表现分析[J].中华医学杂志,2006,86(31):2161-2165. 被引量:79
  • 4陆芸,马宝通,郭若霖,张建国,吴英华,庞贵根,辛景义,叶伟胜,邹玉安,王毅,董强,王学谦,Kerry H,Paul C,John F.骨科创伤患者深静脉血栓危险因素的研究[J].中华骨科杂志,2007,27(9):693-698. 被引量:244
  • 5Hirsh J, Fuster V, Ansell J, et al. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. J Am Coil Cardiol, 2003,41:1633-1652.
  • 6Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007, 146:S57-867.
  • 7Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coil Cardiol, 2008, 52: 865-868.
  • 8Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med, 2005,352:2285-2293.
  • 9Aithal GP, Day CP, Kesteven PJ, et al. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet, 1999, 353:717-719.
  • 10Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141 (2 Suppl) :eddS- 88S.

共引文献1891

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部